The report “Genome Editing / Genome Engineering Market by Application (Cell Line Engineering, Animal & Plant Genetic Engineering), Technology (CRISPR, Antisense, TALEN, Zinc Finger Nuclease), & End User (Biotechnology & Pharmaceutical, CRO) - Global Forecast to 2019”, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global genome editing market along with the estimates and forecasts of the revenue and market share analysis.Browse 83 market data tables and 91 figures spread through 170 pages and in-depth TOC on “Genome Editing / Genome Engineering Market
Inquire more about Report:
http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=231037000
The application segments of genome editing will be important revenue pockets for the genome editing market during the forecast period (2014–2019). The application segments of the genome editing market include cell line engineering, animal genetic engineering, plant genetic engineering, and other applications (diagnostic and therapeutic applications). In 2014, the cell line engineering segment accounted for the largest share of the genome editing market. However, the animal genetic engineering segment is expected to grow at the highest rate during the forecast period. Genetically engineered animals can also be genetically modified to enhance specific characteristics including milk production and disease resistance, as well as to improve the nutritional value of the products they are farmed for. For example, cows, goats, and sheep have been genetically engineered to express specific proteins in their milk.
Get Customized Report:
http://www.marketsandmarkets.com/requestCustomization.asp?id=231037000
In 2014, North America accounted for the largest share of the global genome editing market. However, the Asian market is expected to grow at the highest rate during the forecast period. Growth in the Asian region is likely to be centered on Japan and China. The expansion of leading genome editing companies in Asia will enhance the market in this region. In March 2013, Horizon Discovery Group plc (U.K.) established three new Centers of Excellence (CoE) for gene editing. The new centers are located at Aichi Cancer Center (Japan), Seoul National University (South Korea), and the National Cancer Centre (NCC) (Singapore). This would drive the overall genome editing market in Asia.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com